Learning from Case Law: Case C‑456/24, AG opinion on whether or not a Supplementary Protection certificate (SPC) can be granted for an excipient

This post is an attempt to provide salient information on Case C-456/24 which concerns Halozyme Inc. vs the Supreme Administrative Court, Czech Republic. Specifically, it concerns the events leading up to the CJEU getting involved in the case as well…

Read MoreLearning from Case Law: Case C‑456/24, AG opinion on whether or not a Supplementary Protection certificate (SPC) can be granted for an excipient

FAST-EU, a pilot initiative that enables an accelerated assessment of multinational clinical trials in the European Union

Last updated: 12 May 2026 For updates, click on the ‘+’ sign below. This post aims to provide basic information on the FAST-EU initiative. The information is by no means exhaustive. What is the FAST-Initiative? FAST-EU (Facilitating and Accelerating Strategic…

Read MoreFAST-EU, a pilot initiative that enables an accelerated assessment of multinational clinical trials in the European Union

Amendments to the EU variations regulation and new variations guidelines

EU Variations update

Last updated: 4 March 2026 To view updates, click on the ‘+’ sign below. This post provides information on the changes to the EU the variation Regulation (EC) No 1234/2008 and guidelines. Legal Framework What are some of the changes introduced…

Read MoreAmendments to the EU variations regulation and new variations guidelines

EMA launches pilot to support development of ‘breakthrough’ medical devices in the EU

Last updated: 6 May 2026 To view updates, click on the ‘+’ sign below. The EMA has launched a pilot programme to support the development of breakthrough medical devices in the European Union (EU). EMA launched this pilot on 28 April 2026.…

Read MoreEMA launches pilot to support development of ‘breakthrough’ medical devices in the EU

A closer look at some aspects of the proposed revision of the EU pharmaceutical legislation

Image with TIME FOR TEXT written on it

Last updated: 5 May 2026 On 26 April 2023, the European Commission published its pharmaceuticals reform proposal for more accessible, affordable and innovative medicines. This was covered in a previous post. This post is an attempt to taker a closer…

Read MoreA closer look at some aspects of the proposed revision of the EU pharmaceutical legislation